About a month ago, I woke up without hearing in my left ear. I initially suspected a wax blockage or a blocked eustachian ...

Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 ...

The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

New research from the Monell Chemical Senses Center and Temple University about nutritional biomarkers using carbon and ...

The unfolded protein response (UPR) is a crucial signaling network that preserves endoplasmic reticulum (ER) homeostasis, impacting both health and disease. When ER stress occurs, often due to an ...

Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked ... it led to an increase in peak C-peptide—a biomarker of insulin production ...

Global Experts across the Diabetes Field have also Recognized the Significance of these Findings: “Icovamenib's recent data has shown an impressive restoration of beta cell function as demonstrated by ...

March 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity ... a significant increase in C-peptide production in patients who ...